@article{517e04e87f644553b93e3bd4477e6236,
title = "Impact of pulmonary disease on the prognosis in heart failure with preserved ejection fraction: the TOPCAT trial",
author = "Ramalho, \{Sergio H.R.\} and Claggett, \{Brian L.\} and Sweitzer, \{Nancy K.\} and Fang, \{James C.\} and Shah, \{Sanjiv J.\} and Anand, \{Inder S.\} and Bertram Pitt and Lewis, \{Eldrin F.\} and Pfeffer, \{Marc A.\} and Solomon, \{Scott D.\} and Shah, \{Amil M.\}",
note = "Funding Information: TOPCAT was funded by National Heart, Lung, and Blood Institute, National Institutes of Health (Bethesda, MD), Contract Number HHSN268200425207C. The content of this paper does not necessarily represent the views of the sponsor or of the Department of Health and Human Services. The work for this manuscript was also supported by NIH/NHLBI grants K08HL116792, R01HL135008, and R01HL143224 (Dr. Shah), and a Watkins Discovery Award from the Brigham and Women's Heart and Vascular Center (Dr. Shah). Conflict of interest: A.M.S. has received research support from Novartis and consulting fees from Philips Ultrasound and Bellerophon. All other authors have nothing to disclose. Funding Information: TOPCAT was funded by National Heart, Lung, and Blood Institute, National Institutes of Health (Bethesda, MD), Contract Number HHSN268200425207C. The content of this paper does not necessarily represent the views of the sponsor or of the Department of Health and Human Services. The work for this manuscript was also supported by NIH/NHLBI grants K08HL116792, R01HL135008, and R01HL143224 (Dr. Shah), and a Watkins Discovery Award from the Brigham and Women's Heart and Vascular Center (Dr. Shah). Conflict of interest: A.M.S. has received research support from Novartis and consulting fees from Philips Ultrasound and Bellerophon. All other authors have nothing to disclose. The authors wish to thank the staff and participants of the TOPCAT study for their important contributions. TOPCAT was funded by National Heart, Lung, and Blood Institute, National Institutes of Health (Bethesda, MD), Contract Number HHSN268200425207C. The content of this paper does not necessarily represent the views of the sponsor or of the Department of Health and Human Services. The work for this manuscript was also supported by NIH/NHLBI grants K08HL116792, R01HL135008, and R01HL143224 (Dr. Shah), and a Watkins Discovery Award from the Brigham and Women's Heart and Vascular Center (Dr. Shah). Conflict of interest: A.M.S. has received research support from Novartis and consulting fees from Philips Ultrasound and Bellerophon. All other authors have nothing to disclose.",
year = "2020",
month = mar,
day = "1",
doi = "10.1002/ejhf.1593",
language = "English (US)",
volume = "22",
pages = "557--559",
journal = "European Journal of Heart Failure",
issn = "1388-9842",
publisher = "Oxford University Press",
number = "3",
}